Gapping down
In reaction to disappointing earnings/guidance:
- SNAP -18.8%, DBD -14.9%, YUMC -11.2%, BLDP -9.4%, SSYS -8.4%, SKT -8.2%, PAYC -6.5%, GILD -6.3%, TRUP -5.8%, NBR -5.3%, BPI -4.1%, DENN -3.6%, JBT -3.4%, COHR -3.2%, YUM -3%, NCR -2.9%, NFX -2.8%, NUVA -2.8%, W -2.6%, VRSK -2.5%, EIX -2.3%, QUAD -2.1%, APC -1.9%, CHRW -1.8%, WATT -1.8%, CAMT -1.5%, HSC -1.5%, QUOT -1.3%, MITK -1.3%, ENLC -1.1%, MGPI -1.1%
Other news:
- ESPR -21.3% (reported Q1 and positive top-line results from pivotal Phase 3 long-term safety study of bempedoic acid)
- QURE -6.2% (commences offering of 4 mln ordinary shares)
- KR -1.7% (on reports that Amazon is planning more Prime perks at Whole Foods, including 10% off already discounted items)
- BTX -1.4% (announced the award of a grant of approximately $386,000 from the NIH)
- KPTI -0.8% (proposes public offering of $125 in shares of common stock)
Analyst comments:
- CMI -2.8% (downgraded to Sell from Neutral at UBS)
- NUVA -2.8% (downgraded to Market Perform from Outperform at BMO Capital Markets)
- PCAR -1% (downgraded to Neutral from Buy at UBS)
- ULTA -1% (downgraded to Hold from Buy at Loop Capital)